Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States
about
Recovery efficiency and limit of detection of aerosolized bacillus anthracis Sterne from environmental surface samplesEnvironmental health research in the post-genome era: new fields, new challenges, and new opportunitiesMultigeneration cross contamination of mail with Bacillus species spores by tumblingThe primary care differential diagnosis of inhalational anthraxBinary bacterial toxins: biochemistry, biology, and applications of common Clostridium and Bacillus proteinsDefense at the border: the blood-brain barrier versus bacterial foreignersAnthrax infectionAnimals as sentinels of bioterrorism agentsBacillus anthracis comparative genome analysis in support of the Amerithrax investigationAnthrax in America 2001-2003Furin at the cutting edge: from protein traffic to embryogenesis and diseaseBacillus anthracisHuman monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against Bacillus anthracis infection and enhance endogenous immunity to anthraxInvestigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findingsA software tool for creating simulated outbreaks to benchmark surveillance systems.Epidemiologic investigations of bioterrorism-related anthrax, New Jersey, 2001Isolated case of bioterrorism-related inhalational anthrax, New York City, 2001Inhalational anthrax outbreak among postal workers, Washington, D.C., 2001Opening a bacillus anthracis-containing envelope, Capitol Hill, Washington, D.C.: the public health responseEnvironmental sampling for spores of Bacillus anthracisDoes Bacillus anthracis Lethal Toxin Directly Depress Myocardial Function? A Review of Clinical Cases and Preclinical StudiesAnthrax prophylaxis: recent advances and future directionsPlant-produced candidate countermeasures against emerging and reemerging infections and bioterror agentsAnti-infective immunoadhesins from plants.Bacillus anthracis edema factor substrate specificity: evidence for new modes of actionThe potential contributions of lethal and edema toxins to the pathogenesis of anthrax associated shockBiochemical and structural characterization of alanine racemase from Bacillus anthracis (Ames)Certhrax Toxin, an Anthrax-related ADP-ribosyltransferase from Bacillus cereusAntidotes to anthrax lethal factor intoxication. Part 3: Evaluation of core structures and further modifications to the C2-side chainEvaluation of standardized sample collection, packaging, and decontamination procedures to assess cross-contamination potential during Bacillus anthracis incident response operationsAlternative pre-approved and novel therapies for the treatment of anthraxAnthrax: A disease of biowarfare and public health importanceGram-positive rod surveillance for early anthrax detectionAirborne infection with Bacillus anthracis--from mills to mailProtecting vulnerable populations from pandemic influenza in the United States: a strategic imperativeAntitoxin Treatment of Inhalation Anthrax: A Systematic ReviewAntimicrobial Treatment for Systemic Anthrax: Analysis of Cases from 1945 to 2014 Identified Through a Systematic Literature ReviewUse of two selective media and a broth motility test can aid in identification or exclusion of Bacillus anthracis.Interferon protects mice against inhalation anthraxUse of an in vitro pharmacodynamic model to derive a linezolid regimen that optimizes bacterial kill and prevents emergence of resistance in Bacillus anthracis
P2860
Q23911053-212396AA-8151-4B99-8498-36A3B76B4ED3Q23914178-E5244635-1953-4E78-821F-7898C292E5C9Q23914492-786BE270-71E1-4A76-B37E-AE02F60C0F8DQ24544609-A2A81D49-257C-4E4A-8C84-EC33D6FFE1A2Q24562788-4E67F751-1DCA-4C37-A067-334E7A2C34DEQ24610752-36A190FD-596A-4A3A-9F9E-0D151403F367Q24616676-6C7389F6-4704-482D-AA4C-E82AB12E1413Q24623783-39A8AB6B-0B96-4362-82C8-E563E9F5ED26Q24632034-7312CECB-2860-481C-B5BF-48535AF7F4D1Q24650441-2987C5C3-8CBD-4FA1-9F64-1F49C1BFE2BAQ24670432-0597F44C-3AB8-44C6-857E-1327A8D78F6FQ24672893-ADCC238E-9701-42A0-9C24-31A616C05CCFQ24682011-BFD6E816-074F-46A7-867D-FB2024B37C9CQ24718884-F9017B71-2238-42F0-B93C-468624D8E479Q24816566-8220C9D9-8B7C-4921-A2A4-041440D7CE0FQ24997458-8143F95D-468E-4741-AFDA-697686FEF80EQ24999074-4BF9E45A-C723-49B2-8CC5-53E3799CFCD7Q26154903-F3579C86-F1A4-48D2-ADEC-B072957C6E7AQ26155001-4E032F36-1EB9-477E-BE3E-DA65961545E2Q26158688-787A705D-59A0-41A4-9642-8CFFAE406E4DQ26772000-14D688CE-9269-4133-910F-E33829C27203Q26781366-B05EBCDD-C10C-44AB-9C1D-CDECA88F90FCQ26783107-19BBEEB8-9B23-4401-A678-305B64C98B4AQ26799080-161CEF7C-1662-4E31-8F28-EA6B006EE2B7Q27000357-32E3DC3F-0FFE-4E0B-A024-28AA19A4B56AQ27024163-6B93F1EA-FECF-451C-B340-4A7003BAA549Q27657095-3686D80D-5E71-439D-8A10-B35D753747B5Q27673416-FEA8D27E-38B1-4D65-9F81-8A0532E29053Q27677320-14209F29-767B-4C78-ABDC-BAC11CB7A60DQ27908527-04E16263-D36C-4782-AD22-D0CF3C84B30CQ28075453-54B3F021-0975-4C32-8739-2D9D3A23AD77Q28082022-1A3A3FCD-93EF-443A-BB7B-9225B67553A8Q28382800-5E8957FD-96AC-40D9-BAC5-2F6B692733B3Q28383236-BC8F298E-2406-43D2-927C-F91A4FEC00AEQ28383624-F495E872-F7E6-4E0A-A1F9-3FD936A1F687Q28383765-2FF7DF6D-C50D-4088-BF18-6EFADB5DE66EQ28383825-0B0D7CBA-C4D0-4E61-BB5D-D281A2C73C58Q28384513-78D0AA8B-1689-4DD8-94AA-FF9590F081E0Q28384715-8CA12878-B93B-4BBA-A20C-23980120961DQ28384759-AE4A9C25-D852-42BD-8F2D-2F6A53F26649
P2860
Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States
description
2001 nî lūn-bûn
@nan
2001 թուականին հրատարակուած գիտական յօդուած
@hyw
2001 թվականին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Bioterrorism-related inhalatio ...... reported in the United States
@ast
Bioterrorism-related inhalatio ...... reported in the United States
@en
Bioterrorism-related inhalatio ...... reported in the United States
@nl
type
label
Bioterrorism-related inhalatio ...... reported in the United States
@ast
Bioterrorism-related inhalatio ...... reported in the United States
@en
Bioterrorism-related inhalatio ...... reported in the United States
@nl
prefLabel
Bioterrorism-related inhalatio ...... reported in the United States
@ast
Bioterrorism-related inhalatio ...... reported in the United States
@en
Bioterrorism-related inhalatio ...... reported in the United States
@nl
P2093
P2860
P921
P3181
P356
P1476
Bioterrorism-related inhalatio ...... reported in the United States
@en
P2093
B A Perkins
C W Shepard
D A Ashford
D S Stephens
J A Jernigan
J J Sejvar
J L Gerberding
J M Hughes
P2860
P304
P3181
P356
10.3201/EID0706.010604
P407
P577
2001-01-01T00:00:00Z